Literature DB >> 24270242

Limelight on alpha-synuclein: pathological and mechanistic implications in neurodegeneration.

Pauline Wales1, Raquel Pinho, Diana F Lázaro, Tiago F Outeiro.   

Abstract

The pathogenesis of many neurodegenerative disorders arises in association with the misfolding and accumulation of a wide variety of proteins. Much emphasis has been placed on understanding the nature of these protein accumulations, including their composition, the process by which they are formed and the physiological impact they impose at cellular and, ultimately, organismal levels. Alpha-synuclein (ASYN) is the major component of protein inclusions known as Lewy bodies and Lewy neurites, which are the typical pathological hallmarks in disorders referred to as synucleinopathies. In addition, mutations or multiplications in the gene encoding for ASYN have also been shown to cause familial cases of PD, the most common synucleinopathy. Although the precise function of ASYN remains unclear, it appears to be involved in a vast array of cellular processes. Here, we review, in depth, a spectrum of cellular and molecular mechanisms that have been implicated in synucleinopathies. Importantly, detailed understanding of the biology/pathobiology of ASYN may enable the development of novel avenues for diagnosis and/or therapeutic intervention in synucleinopathies.

Entities:  

Keywords:  Alpha-synuclein; Lewy body; aggregation; neurodegeneration; synucleinopathies

Mesh:

Substances:

Year:  2013        PMID: 24270242     DOI: 10.3233/JPD-130216

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.568


  28 in total

1.  Subcellular Parkinson's Disease-Specific Alpha-Synuclein Species Show Altered Behavior in Neurodegeneration.

Authors:  Rashed Abdullah; Ketan S Patil; Benjamin Rosen; Ramavati Pal; Shubhangi Prabhudesai; Sungsu Lee; Indranil Basak; Esthelle Hoedt; Peter Yang; Keith Panick; Hsin-Pin Ho; Emmanuel Chang; Charalampos Tzoulis; Jan Petter Larsen; Thomas A Neubert; Guido Alves; Simon G Møller
Journal:  Mol Neurobiol       Date:  2016-11-11       Impact factor: 5.590

2.  Pure autonomic failure versus prodromal dysautonomia in Parkinson’s disease: Insights from the bedside.

Authors:  Aristide Merola; Alberto J Espay; Maurizio Zibetti; Alberto Romagnolo; Michela Rosso; Simona Maule; Leonardo Lopiano
Journal:  Mov Disord Clin Pract       Date:  2016-05-19

3.  Novel conformation-selective alpha-synuclein antibodies raised against different in vitro fibril forms show distinct patterns of Lewy pathology in Parkinson's disease.

Authors:  D J Covell; J L Robinson; R S Akhtar; M Grossman; D Weintraub; H M Bucklin; R M Pitkin; D Riddle; A Yousef; J Q Trojanowski; V M-Y Lee
Journal:  Neuropathol Appl Neurobiol       Date:  2017-05-15       Impact factor: 8.090

4.  Cognitive and motor functioning in elderly glucocerebrosidase mutation carriers.

Authors:  Eileen E Moran; Cuiling Wang; Mindy Katz; Laurie Ozelius; Alison Schwartz; Jelena Pavlovic; Roberto A Ortega; Richard B Lipton; Molly E Zimmerman; Rachel Saunders-Pullman
Journal:  Neurobiol Aging       Date:  2017-06-24       Impact factor: 4.673

Review 5.  The Interplay between Alpha-Synuclein Clearance and Spreading.

Authors:  Tomás Lopes da Fonseca; Anna Villar-Piqué; Tiago Fleming Outeiro
Journal:  Biomolecules       Date:  2015-04-14

6.  Sigma-1 receptor: a potential new target for Parkinson's disease?

Authors:  Veronica Francardo
Journal:  Neural Regen Res       Date:  2014-11-01       Impact factor: 5.135

Review 7.  ATP13A2 and Alpha-synuclein: a Metal Taste in Autophagy.

Authors:  Tomás Lopes da Fonseca; Tiago Fleming Outeiro
Journal:  Exp Neurobiol       Date:  2014-12-12       Impact factor: 3.261

Review 8.  Posttranslational Modifications and Clearing of α-Synuclein Aggregates in Yeast.

Authors:  Blagovesta Popova; Alexandra Kleinknecht; Gerhard H Braus
Journal:  Biomolecules       Date:  2015-04-23

9.  DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease.

Authors:  L Zondler; L Miller-Fleming; M Repici; S Gonçalves; S Tenreiro; R Rosado-Ramos; C Betzer; K R Straatman; P H Jensen; F Giorgini; T F Outeiro
Journal:  Cell Death Dis       Date:  2014-07-24       Impact factor: 8.469

Review 10.  Alpha-Synuclein Post-translational Modifications: Implications for Pathogenesis of Lewy Body Disorders.

Authors:  Nelson de Oliveira Manzanza; Lucia Sedlackova; Raj N Kalaria
Journal:  Front Aging Neurosci       Date:  2021-06-25       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.